Vinati Organics Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 31 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹13.8K Cr
FY26 growth was similar to FY25, around 5%. FY26 growth was modest at around 5% compared to FY25.
From Vinati Organics Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹1,329
Market Cap
₹13.8K Cr
P/E Ratio
27.6
Revenue Rank
Margin Rank
How does Vinati Organics Ltd rank in Chemicals & Petrochemicals?
Compare Vinati Organics Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Vinati Organics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹611 Cr, net profit ₹138 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 3- →FY26 growth was similar to FY25, around 5%.
- →Targeting approximately 15% volume growth at the company level in FY27.
- →Antioxidants segment delivered 15% revenue growth in FY26 and expected to maintain strong momentum in FY27.
- →ATBS expected to see 15% volume growth year-on-year for the next 3 years.
- →Butyl phenols expect moderate growth in FY27.
- →IB and HP-MTBE expected to achieve double-digit growth in FY27.
- →IBB volumes declined in FY26 due to raw material unavailability but production and sales are now back on track.
- →Customized products showed strong 10% year-on-year growth, expected to continue.
- →Long-term growth planned via organic expansion with INR250-300 crores annual investment for 3-5 years.
- →Revenue from new products including AO and butyl phenols expected to reach INR800-900 crores in next 2 years.
📈 Profitability & Margins
Rank 3- →FY26 growth was modest at around 5% compared to FY25.
- →Antioxidants segment expects continued strong momentum and market expansion, supporting growth.
- →ATBS segment anticipates approximately 15% volume growth year-on-year for the next 3 years.
- →Butyl phenols segment expects moderate growth supported by improving demand.
- →IB and HP-MTBE products forecast double-digit growth in FY27.
- →IBB production and sales have normalized after prior raw material challenges.
- →Overall company targets approximately 15% volume growth in FY27.
- →EBITDA margin guidance maintained at 26%-27% for the long term.
- →Capex of INR 200-250 crores planned for FY27 focused on capacity expansion and new product introductions.
- →VOPL subsidiary expected to contribute revenues (~INR100-120 crores) starting Q3 FY27 after process reengineering.
- →Company remains debt-free and funded through internal accruals, indicating strong financial health supporting growth.
🏗️ Capital Expenditure Plans
Yes- →FY26 capex was approximately INR 270 crores, including investments in VOPL for capacity expansion, new product development, and operational scalability.
- →FY27 capex is earmarked at around INR 200-250 crores focusing on capacity expansion, innovation, and operational efficiency.
- →Major portion (~INR 200 crores) of FY27 capex will be through the main holding company Vinati Organics Limited; INR 40-50 crores through subsidiary VOPL.
- →The ATBS capacity expansion completed, with further utilization expected from FY28 onwards.
- →Process reengineering at VOPL expected to be completed by September 2026; revenue contribution from Q3 FY27.
- →New products under R&D targeting niche chemicals for industries such as food additives, fragrance, personal care, antioxidants, and plastics.
- →Investment plans continue to be financed through internal accruals; the company remains debt-free with treasury of ~INR 190 crores as of March 31, 2026.
💰 Fundraising & Capital Structure
No- →Vinati Saraf Mutreja stated the company is focusing on organic expansion with a pipeline of products and plans to invest INR250-300 crores annually for the next 3 to 5 years.
- →The company has been achieving all expansion goals through internal accruals and remains debt-free.
- →There is no mention of plans for raising new funds through equity or debt in the transcript.
- →The management confirmed that they will continue the policy of no debt going forward.
- →The company has a treasury of approximately INR190 crores as of March 31, 2026, supporting their financial stability without external financing.
📋 Order Book & Pipeline
No information- →No explicit mention of a current or expected order book or pending orders was made in the transcript.
- →For ATBS, capacity utilization is about 75-80%, indicating healthy demand, but no specific backlog figures were shared.
- →Management indicated stable industry growth with expectations of approximately 15% volume growth in FY27.
- →No direct references to order backlog numbers or pending orders were given during the Q&A.
- →The company is focusing on organic expansion with planned capex of INR250-300 crores annually for product development and capacity enhancement.
- →Process reengineering for certain products in the subsidiary VOPL is expected to end by September, with revenue starting from Q3 FY27.
- →Management highlighted stable raw material availability and logistics, supporting uninterrupted fulfillment of orders.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Vinati Organics Ltd Q4 FY26 results?
FY26 growth was similar to FY25, around 5%. FY26 growth was modest at around 5% compared to FY25.
What is Vinati Organics Ltd share price analysis?
Vinati Organics Ltd currently shows a below-average growth signal. The stock trades at a P/E of 27.6 with a market cap of ₹13,764 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vinati Organics Ltd planning capital expenditure?
FY26 capex was approximately INR 270 crores, including investments in VOPL for capacity expansion, new product development, and operational scalability.
Keep Vinati Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.